Based on the close relationship between dysregulation of redox homeostasis and immune response in SARS-CoV-2 infection, we proposed a possible modifying role of ACE2 and glutathione transferase omega (GSTO) polymorphisms in individual propensity towards the development of clinical manifestations in COVID-19. Here, ACE2 is linked to COVID-19.